Under CARRRP, ATCC will assume management of biomaterials from NIAID’s Vaccine Research Center. Manassas, VA, United States — ATCC, the world’s premier biological materials management and standards organization, today announced that it has been awarded a Task Order under an Indefinite Delivery/Indefinite Quantity (IDIQ) contract by the National Institute of Allergy and Infectious Diseases (NIAID), part of […]
Gothenburg based ConScience AB and partners funded two grants totalling 10MSEK for developing nanofluidic imaging technology and neuromorphic computing. GOTHENBURG, SWEDEN, SWEDEN — The Gothenburg based company ConScience AB has together with partners been funded two grants totaling 10MSEK for developing advanced nanofluidic imaging technology and neuromorphic computing. In the first project, ConScience will be developing Nanofluidic […]
AMSBIO has announced a new range of customizable ELISA assay kits designed to enable experienced researchers to achieve reliable and reproducible assay results. With over 500 ELISA kits to choose from, the new range covers a wide variety of biological processes, targets, and sample types. Reagents such as matched antibody pairs and a micro-ELISA pre-plate have been carefully […]
BRANFORD, Conn. — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it had entered into an agreement with Elta 90 to distribute Quantum-Si’s groundbreaking Platinum™ instrument and consumables in Southeast Europe as demand grows for the first of its kind next-generation protein sequencing™ platform. This agreement between Quantum-Si and ELTA 90 holds […]
ACROBiosystems, a global cornerstone of the pharmaceutical industry committed to offering innovative tools and solutions, announces the launch of GMP grade DLL4. GMP grade DLL4 is the first recombinant Delta-like Ligand 4, or DLL4, to be launched on the market under GMP conditions. The availability of DLL4 manufactured under GMP conditions represents a significant milestone […]
ACROBiosystems, a global cornerstone of the pharmaceutical industry committed to offering innovative tools and solutions, announces the launch of GMP grade DLL4. GMP grade DLL4 is the first recombinant Delta-like Ligand 4, or DLL4, to be launched on the market under GMP conditions. The availability of DLL4 manufactured under GMP conditions represents a significant milestone […]
Non-infectious TiterSafe particles can be used as a virus substitute in hemagglutination inhibition (HAI) assays to test influenza vaccine efficacy. Philadelphia – Integral Molecular, a leading provider of reagents for vaccine evaluation, announces the launch of TiterSafe™ influenza virus-like particles, an off-the-shelf virus-alternative for key experiments in testing influenza vaccines. Titersafe is a safe and convenient […]
Greg Herrema to Spearhead Next Phase of Global Biospecimen and Biomarker Company’s Expansion HUNTSVILLE, Ala. — Discovery Life Sciences, the Biospecimen and Biomarker Specialists, announced today the appointment of Greg Herrema as its new chief executive officer. A leader with more than 20 years of experience across the life sciences and industrial sectors, Mr. Herrema […]
Creative BioMart, a leading provider of recombinant protein and custom protein services, announces that it now offers a wide range of biomarker proteins for research use. Biomarker proteins are molecules that can be used to measure and monitor biological processes, including those associated with disease. They have the potential to revolutionize medicine by enabling personalized […]
UPPSALA, Sweden — Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that Novogene Asia Pacific Middle East and Africa (AMEA) has adopted the Olink Explore HT platform to deliver advanced next-generation proteomics technology to the scientific community in the region. Novogene is a leading provider of genomic services and solutions offering extensive next generation […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
